EXACT Sciences Corporation Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 27 Posts
1 2
E Exact Sciences Is Going Higher
Article By: Quad 7 Capital Tuesday, July 30, 2019 12:23 PM EST
With the merger of Exact Sciences and Genomic Health, investors should be looking for EXAS earnings positive results by the end of 2020. In the meantime, revenue growth continues to be astounding.
In this article: EXAS, GHDX Also: PFE
Read
Triple Play Acquiring Triple Play
Article By: Bespoke Investment Group Monday, July 29, 2019 1:14 PM EST
Exact Sciences announced plans today to acquire another health care company, Genomic Health. The two announced that the agreement would combine Exact Sciences with Genomic Health for $72 per share in cash and stock.
In this article: GHDX, EXAS
Read
Exact Sciences Will Acquire Genomic Health In $2.8B Deal
Article By: Benzinga Monday, July 29, 2019 9:37 AM EST
Exact Sciences Corp. will acquire Genomic Health, Inc. for $72 per share in a cash and stock transaction valued at $2.8 billion.
In this article: GHDX, EXAS
Read
Stocks For You To Swing-Trade: EXAS, UNM, ROKU
Article By: Ryan Mallory Wednesday, April 17, 2019 7:35 AM EST
Take a look at three trading ideas to prep you for the next trading session.
In this article: UNM, EXAS, ROKU
Read
5 Stocks That May Sink The Market, Do Bonds Have A Secret Message
Article By: Michael J. Kramer Tuesday, February 26, 2019 9:32 AM EST
US bonds are still very attractive compared to global rates and the spreads for US bonds got too wide and are now reverting to the mean.
In this article: SPY, TNX, CAT, HD, EXAS, GS, FB
Read
Exact Sciences: Poised For Further Growth
Article By: TipRanks Sunday, November 4, 2018 3:17 PM EST
Exact Sciences is moving forward on a solid foundation: a proven product, a new marketing initiative to expand – or even double – its reach. It’s no surprise that every analyst who has reviewed EXAS recently has given it a ‘Buy’ rating
In this article: PFE, EXAS
Read
Weighing The Week Ahead: Should Investors Worry About The Yield Curve?
Article By: Jeff Miller Sunday, August 26, 2018 11:27 AM EST
Much of the punditry is focused on a death watch for the bull market, with daily discuss of the flattening yield curve and speculation about when it will “invert.” This is not the right question.
In this article: AXL, MO, AMZN, TSLA, SPX, OLLI, LOW, NVAX, EXAS
Read
10 Stock Tips From The Street’s Best Analysts
Article By: TipRanks Sunday, July 29, 2018 4:39 PM EST
Using the updated stock screener from the generated results, these 10 stocks stood out. Bear in mind the analyst consensus is based on ratings from the last three months.
In this article: EW, MA, MPC, MPWR, AMZN, MU, EXAS, GOOGL, WIX, RETA
Read
E Large Cap Stocks: Gainers And Losers In 2017
Article By: Arie Goren Saturday, December 30, 2017 12:24 PM EST
Here are the best and the worst performers among Russell 1000 stocks in 2017, and 20 stocks that have a chance to perform well in 2018, which should be another good year for investors in large cap stocks.
In this article: AN, LEN, OPK, RAD, RRC, UHS, ALNY, SBNY, EXAS, BLUE, ESNT, EVHC, SQ, UAA, OLED Also: IWB
Read
5 Top-Ranked Profitable Stocks To Boost Your Portfolio
Article By: Zacks Investment Research Tuesday, October 17, 2017 3:24 PM EST
Profitability analysis is used to measure the company’s ability to manage its revenues effectively and provide stunning returns to its investors.
In this article: NTDOY, NVMI, EXAS, FB, TRHC
Read
Analysts Bullish On Exact Sciences After Positive Coverage Decision
Article By: The Fly Wednesday, May 31, 2017 2:40 PM EST
The shares of EXACT Science are climbing after health insurance giant UnitedHealth agreed to cover the company's Cologuard test, starting July 1.
In this article: EXAS Also: UNH
Read
Exact Sciences - Chart Of The Day
Article By: Jim Van Meerten Monday, May 8, 2017 3:04 PM EST
Revenue expected to grow 109.00% this year and another 49.80% next year.
In this article: EXAS
Read
Exact Sciences (EXAS) "Cup 'N Handle" Chart Is Bullish
Article By: Adam Makowka Thursday, March 2, 2017 10:00 PM EST
2-yr weekly illustrates a "Cup 'n Handle" an imminent breakout is expected.
In this article: EXAS
Read
Exact Sciences Reports Positive Results From Lung Cancer Test Study
Article By: KKD Healthcare Analytics Thursday, March 2, 2017 2:24 PM EST
Exact Sciences Corporation reported that its collaboration with Mayo Clinics for developing a blood-based lung cancer test shows promising prospects.
In this article: EXAS
Read
Drug Stocks Q4 Earnings Lineup For Feb 21: IRWD, MNTA, EXAS
Article By: Zacks Investment Research Tuesday, February 21, 2017 4:30 AM EST
Momenta’s bottom-line performance has been decent so far, with its earnings surpassing expectations in three of the last four quarters. However, over the trailing four quarters, the company has recorded an average negative surprise of 75.74%.
In this article: MNTA, EXAS, IRWD Also: ALXN, TEVA, ZTS
Read
5 Great Biotech Stocks To Buy Now
Article By: Swarup Gupta Tuesday, February 7, 2017 5:45 PM EST
Biotechs have recovered substantially from the losses they suffered up to early last year. Adding biotech stocks to your portfolio looks like a smart option at this point.
In this article: CELG, CLLS, EXEL, EXAS, SNSS Also: BMRN
Read
1 to 16 of 27 Posts
1 2